The drug daraxonrasib nearly doubled the overall survival rates of pancreatic cancer patients. Here's how it works and who ...

By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's experimental pancreatic cancer pill doubled survival ...

A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in ...

A new daily pill called daraxonrasib is showing promise against advanced pancreatic cancer in a first-in-human trial of 168 ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

Weight loss drugs were linked to a major shift in cancer survival in a new study.

Phase 3 results showed the treatment nearly doubled survival for patients with previously treated metastatic pancreatic ...

People with advanced pancreatic cancer taking an experimental daily pill lived nearly twice as long as those receiving ...